Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.
It’s clear there’s a strong connection between sustained earnings growth and hall-of-fame returns. Taking that into account, here are three market-beating stocks with room for further growth.
Robinhood (HOOD)
Five-Year Return: +170%
With a mission to democratize finance, Robinhood (NASDAQ:HOOD) is an online consumer finance platform known for its commission-free stock and crypto trading.
Why Will HOOD Beat the Market?
- Switching costs of its platform were on full display over the last two years as it not only grew engagement but also increased the average revenue per user by 91.2% annually
- Performance over the past three years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
- Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends
At $123.85 per share, Robinhood trades at 34.8x forward EV/EBITDA. Is now the time to initiate a position? See for yourself in our full research report, it’s free.
Medpace (MEDP)
Five-Year Return: +234%
Founded in 1992 as a scientifically-driven alternative to traditional contract research organizations, Medpace (NASDAQ:MEDP) provides outsourced clinical trial management and research services to help pharmaceutical, biotechnology, and medical device companies develop new treatments.
Why Do We Watch MEDP?
- Existing business lines can expand without risky acquisitions as its organic revenue growth averaged 17.2% over the past two years
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 29.6% exceeded its revenue gains over the last five years
- Free cash flow margin jumped by 6 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
Medpace’s stock price of $651.52 implies a valuation ratio of 33.8x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
Gulfport Energy (GPOR)
Five-Year Return: +98.3%
With drilling operations focused on the Utica Shale in eastern Ohio and the SCOOP play in central Oklahoma, Gulfport Energy (NYSE:GPOR) drills for and produces natural gas from underground shale formations.
Why Do We Like GPOR?
- Annual revenue growth of 10.8% over the last ten years was superb and indicates its market share increased during this cycle
- Highly-profitable operating model results in strong unit economics and a top-tier gross margin of 70.9%
- Strong free cash flow margin of 17% enables it to reinvest or return capital consistently
Gulfport Energy is trading at $158.61 per share, or 6.3x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.